These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2648174)
1. [ISIS-2, an international study of survival after a heart infarct: the power of large numbers?]. Koster RW Ned Tijdschr Geneeskd; 1989 Feb; 133(7):338-40. PubMed ID: 2648174 [No Abstract] [Full Text] [Related]
2. [Systemic thrombolysis using streptokinase. Experiences at the Civic Hospital of Lugano in the framework of the ISIS-2 study]. Moccetti T; Rezzonico M; Clara F; Riva A; Tanzi F; Genoni M; Malacrida R Schweiz Med Wochenschr; 1988 Nov; 118(46):1702-5. PubMed ID: 3212423 [TBL] [Abstract][Full Text] [Related]
3. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study. Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430 [TBL] [Abstract][Full Text] [Related]
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):3A-13A. PubMed ID: 2903874 [TBL] [Abstract][Full Text] [Related]
6. Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study. Schröder R; Neuhaus KL; Linderer T; Leizorovicz A; Wegscheider K; Tebbe U Circulation; 1987 Aug; 76(2 Pt 2):II44-51. PubMed ID: 3301056 [No Abstract] [Full Text] [Related]
7. [First results of a randomized study of intravenous thrombolytic therapy in acute myocardial infarct--evaluation of the early period]. Janousek S; Lupínek Z; Toman J; Suchánek M; Chaloupka V; Breinek P; Penka M; Elbl L; Snízková J; Soucek R Vnitr Lek; 1988 Dec; 34(12):1145-54. PubMed ID: 3066009 [No Abstract] [Full Text] [Related]
8. [ISIS-2--a study of patients with myocardial infarction. A combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke]. Wilhelmsen L Lakartidningen; 1988 Aug; 85(35):2759-64. PubMed ID: 3047513 [No Abstract] [Full Text] [Related]
9. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981 [TBL] [Abstract][Full Text] [Related]
10. Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet; 1987 Feb; 1(8531):502. PubMed ID: 2881054 [No Abstract] [Full Text] [Related]
11. Acute myocardial infarction: a true medical emergency. White HD N Z Med J; 1989 Jun; 102(869):281-3. PubMed ID: 2499853 [No Abstract] [Full Text] [Related]
12. [Intravenous streptokinase therapy in acute myocardial infarct in a district hospital]. Ziegler H Schweiz Med Wochenschr; 1988 Nov; 118(46):1698-701. PubMed ID: 3212422 [TBL] [Abstract][Full Text] [Related]
13. [Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2]. Madsen JK; Pedersen F; Amtoft A; Deding A; Grande P; Hansen JN; Hilden M; Hornum I; Jensen T; Lindskov J Ugeskr Laeger; 1989 Oct; 151(40):2565-9. PubMed ID: 2683281 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy in myocardial infarct and its assumptions. Experiences of the Italian Group for the Study of Streptokinase in Myocardial Infarct]. G Ital Cardiol; 1987 Jan; 17(1):9-13. PubMed ID: 3552844 [No Abstract] [Full Text] [Related]
15. Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute myocardial infarction. Bonan R Can J Cardiol; 1987 Nov; 3 Suppl A():30A-33A. PubMed ID: 2963686 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction. Mock MB; Chesebro JH Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892 [No Abstract] [Full Text] [Related]
18. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. Stampfer MJ; Goldhaber SZ; Yusuf S; Peto R; Hennekens CH N Engl J Med; 1982 Nov; 307(19):1180-2. PubMed ID: 6750403 [No Abstract] [Full Text] [Related]
19. [The ISIS-2 study (International Study of Infarction Survival)]. Boissel JP Rev Prat; 1988 Jun; 38(19):1285-8. PubMed ID: 3175499 [No Abstract] [Full Text] [Related]
20. [Intravenous streptokinase versus heparin in fresh acute myocardial infarct. Randomized multicenter study in Franche-Comté]. Bassand JP; Faivre R; Becque O; Habert C; Schuffenecker M; Petiteau PY; Cardot JC; Verdenet J; Laroze M; Maurat JP Haemostasis; 1986; 16 Suppl 4():135-44. PubMed ID: 3533733 [No Abstract] [Full Text] [Related] [Next] [New Search]